Gsk Share Discussion Threads

[chc15] 26/6/2024 19:49

Lol this is nonsense, u need to look at holding announcements to know what's really going on. Check out 3i Group, it's last two holding announcements says it all. GSK is forever in the doldrums, although I have bought some at 1600 recently.

[pj84] 26/6/2024 11:40

The top 10 UK stocks the world’s best managers are buying

GSK no.4 in the list

[dplewis1] 25/6/2024 08:21

Yes, I agree. Thanks for bringing the point alive with the Prince Andrew analogy :)

[laurence llewelyn binliner] 25/6/2024 08:05

#dplewis, settling out of court is not always an admission of guilt, in some cases it is more cost effective and reputation damage limitation from the fallout of years of extended litigation..

In some cases it does nothing to dampen speculation though, ref our Prince that does not sweat.. (much).. :o)

[dplewis1] 25/6/2024 07:53

If there's no link to causing cancer why are they settling?

[tradermichael] 24/6/2024 08:09

GSK's Omjjara (momelotinib) approved in Japan for treatment of myelofibrosis


· Omjjara approved for use in both newly diagnosed or previously treated myelofibrosis patients
· Differentiated mechanism of action addresses key manifestations of myelofibrosis, namely anaemia, constitutional symptoms and splenomegaly
· In Japan, about 70% of patients diagnosed with primary myelofibrosis have moderate to severe anaemia at the time of diagnosis.

[tradermichael] 20/6/2024 09:32

GlaxoSmithKline Biologicals SA (GSK), a global leader in pharmaceuticals, and Imperial College London have announced a significant partnership.

This landmark agreement marks the beginning of an intensive exploration into the safety and efficacy of next generation thermostable RNA formulations and is a step forward in the realm of RNA-based vaccines through a 12-month validation study.

The nanoparticles, inspired by nature and developed by Professor Rongjun Chen and co-inventors at Imperial, have shown remarkable promise in protecting RNA-based vaccines and therapeutics and carrying them more effectively into cells. These formulations can enhance stability even at tropical temperatures and substantially reduce the dosage required for treatment.

"This partnership with GSK signifies a pivotal moment in our journey to unlock the full potential of RNA-based vaccines and therapeutics," commented Professor Rongjun Chen. "We are thrilled to embark on this validation study, confident that our innovative formulations will pave the way for safer, more effective and affordable treatments against a range of diseases."
Through this partnership, GSK aims to harness the transformative potential of Imperial’s technologies to advance the development of thermostable RNA-based vaccines. By combining GSK's expertise in pharmaceutical development with Imperial’s ground-breaking formulations, the collaboration holds promise for revolutionising the landscape of vaccine and therapeutic delivery.

The patented technologies have stemmed from the Future Vaccine Manufacturing Research Hub at Imperial, funded by the Department of Health and Social Care using UK Aid funding and managed by the Engineering and Physical Sciences Research Council (EPSRC).

[tradermichael] 18/6/2024 16:07

Sanofi has settled about 4,000 Zantac cases, and the Financial Times reported last month that Pfizer had settled more than 10,000 cases.

[lippy4] 18/6/2024 15:18

how would the jury know,are they all going to be scientists it seems ridiculous that its been dismissed by judges in other states..

[tradermichael] 18/6/2024 15:02

grahamburn18 Jun '24 - 14:55 - 33071 of 33071
0 0 0
Is there a need for it to be heard before a jury, Alibizzle?


“This case has always been about getting the science in front of a jury,” Brent Wisner, lawyer at the firm Wisner Baum which is representing many of the plaintiffs, said in a statement.

[grahamburn] 18/6/2024 14:55

Is there a need for it to be heard before a jury, Alibizzle?

Don't forget that numerous other courts (albeit in other states) have already dismissed the various different plaintiffs scientific/medical evidence before the respective cases came to trial.

[tradermichael] 18/6/2024 08:24

Non-scientifically trained jurors in America can be easily swayed by smart lawyers

[alibizzle] 18/6/2024 07:31

They will lose appeal which I think is fair . It needs to be heard in court all the admissable evidence with all experts and then hopefully dismissed

[laurence llewelyn binliner] 17/6/2024 14:02

23.05.2024 - GSK plc welcomes todays jury verdict in the Valadez case in Illinois state court finding in GSK's favour in the first Zantac case to go to trial. This outcome is consistent with the scientific consensus that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer, supported by 16 epidemiological studies looking at human data regarding the use of ranitidine.

GSK will continue to vigorously defend itself against all other claims

10.06.2024 - The Superior Courts ruling is inconsistent with how the Daubert standard has been applied previously in Delaware and federal courts. As such, differing rulings interpreting how the Daubert standard is to be applied to litigation before Delaware Courts now exist. The Superior Courts ruling would therefore have profound implications for all companies and businesses incorporated in Delaware..

Application has been filed seeking right of appeal to the Delaware Supreme Court, GSK, Pfizer, Sanofi, and Boehringer Ingelheim are all parties to the application..

[alibizzle] 17/6/2024 13:53

Doesn't matter if there is a link or not Micheal

[rikky72] 17/6/2024 12:22

I don't agree with it but I think they may take this option as 70,000 cases going through the courts will create major, prolonged uncertainty. I'm hopeful the appeal will be successful but let's see..

[tradermichael] 17/6/2024 11:43

Why settle when there's no evidence for a causal link?

[rikky72] 17/6/2024 11:11

If they don't win the appeal It's quite likely they will settle then.

[alibizzle] 17/6/2024 11:00

Yeah I agree gsk should settle. Le take the hot and move on

[spoole5] 17/6/2024 09:23

Should have settled. Will drag and drag

[philanderer] 16/6/2024 18:17

The Telegraph

The $3bn crisis casting a shadow over Dame Emma Walmsley’s GSK

[tradermichael] 14/6/2024 13:03

Potential liabilities
It’s worth pointing out that GSK peer Sanofi recently settled about 4,000 Zantac cases for $100m in private, according to Bloomberg. That would imply a payout of $25,000 per plaintiff. Assuming the same amount was (to be) paid for 70,000 lawsuits, GSK’s liability would come to around $1.75bn. That wouldn’t be the end of the world for the company, given that analysts are expecting a net profit of over $8bn this year.

www.fool.co.uk

[alibizzle] 13/6/2024 17:13

Yeah was thinking if price gets to £17 I would make small profit around £400 which is more than I would get 1 year in cash ISA interest

[geckotheglorious] 13/6/2024 15:30

Why not drip feed it in Abibizzle, rather than waiting for a poop n scoop moment?